Northern Trust’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Northern Trust’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-49,134	Closed	-$1.91M	–	4349
2017 Q3	$1.91M	Sell	49,134 -8,277	-14%	-$304K	﹤0.01%	3212
2017 Q2	$1.72M	Buy	57,411 +2,683	+5%	+$69.5K	﹤0.01%	3263
2017 Q1	$1.45M	Buy	54,728 +16,325	+43%	+$404K	﹤0.01%	3225
2016 Q4	$853K	Buy	38,403 +8,833	+30%	+$165K	﹤0.01%	3396
2016 Q3	$547K	Buy	29,570 +2,235	+8%	+$38.7K	﹤0.01%	3491
2016 Q2	$444K	Buy	+27,335	New	+$460K	﹤0.01%	3541

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Northern Trust's NDRM Position: Q4 2017 in Review

Northern Trust sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 49,134 shares — an estimated $1.91M sold.

Northern Trust first reported a position in NDRM in Q2 2016 and held it in 6 quarters. The position peaked at $1.91M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

Northern Trust reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Northern Trust sold 49,134 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.91M.
Northern Trust first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2016 and held it in 6 quarters.
Northern Trust's NeuroDerm Ltd. Ordinary Shares position peaked at $1.91M in Q3 2017.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Northern Trust's 13F filing for Q4 2017, filed 14 Feb 2018.